ESSA Pharma Announces Overnight Marketed Equity Offering

HOUSTON and VANCOUVER, Dec. 12, 2017 /PRNewswire/ - ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) ("ESSA" or the "Company"), a pre-clinical stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, is pleased to announce that...